Functional assessment of the glycoproteins of a novel Hendra virus variant reveals contrasting fusogenic capacities of the receptor-binding and fusion glycoproteins
mBio · 2025
DOI: 10.1128/mbio.03482-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, 2025. Verfasst von Andrew Z Ma und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA. Hauptthemen laut MEDLINE: Hendra Virus, Viral Fusion Proteins, Virus Internalization, Glycoproteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIBIB NIH HHS, DARPA.
Abstract (Originalsprache)
A novel Hendra virus (HeV) genotype (HeV genotype 2 [HeV-g2]) was recently isolated from a deceased horse, revealing high-sequence conservation and antigenic similarities with the prototypic strain, HeV-g1. As the receptor-binding (G) and fusion (F) glycoproteins of HeV are essential for mediating viral entry, functional characterization of emerging HeV genotypic variants is key to understanding viral entry mechanisms and broader virus-host co-evolution. We first confirmed that HeV-g2 and HeV-g1 glycoproteins share a close phylogenetic relationship, underscoring HeV-g2’s relevance to global health. Our in vitro data showed that HeV-g2 glycoproteins induced cell-cell fusion in human cells, shared receptor tropism with HeV-g1, and cross-reacted with antibodies raised against HeV-g1. Despite these similarities, HeV-g2 glycoproteins yielded reduced syncytia formation compared to HeV-g1. By expressing heterotypic combinations of HeV-g2, HeV-g1, and Nipah virus (NiV) glycoproteins, we found that while HeV-g2 G had strong fusion-promoting abilities, HeV-g2 F consistently displayed hypofusogenic properties. These fusion phenotypes were more closely associated with those observed in the related NiV. Further investigation using HeV-g1 and HeV-g2 glycoprotein chimeras revealed that multiple domains may play roles in modulating these fusion phenotypes. Altogether, our findings may establish intrinsic fusogenic capacities of viral glycoproteins as a potential driver behind the emergence of new henipaviral variants. IMPORTANCE HeV is a zoonotic pathogen that causes severe disease across various mammalian hosts, including horses and humans. The identification of unrecognized HeV variants, such as HeV-g2, highlights the need to investigate mechanisms that may drive their evolution, transmission, and pathogenicity. Our study reveals that HeV-g2 and HeV-g1 glycoproteins are highly conserved in identity, function, and receptor tropism, yet they differ in their abilities to induce the formation of multinucleated cells (syncytia), which is a potential marker of viral pathogenesis. By using heterotypic combinations of HeV-g2 with either HeV-g1 or NiV glycoproteins, as well as chimeric HeV-g1/HeV-g2 glycoproteins, we demonstrate that the differences in syncytial formation can be attributed to the intrinsic fusogenic capacities of each glycoprotein. Our data indicate that HeV-g2 glycoproteins have fusion phenotypes closely related to those of NiV and that fusion promotion may be a crucial factor driving the emergence of new henipaviral variants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
- Epidemiology Surveillance and Laboratory Section, Animal Health Policy Branch, Animal Division, Department of Agriculture Fisheries and Forestry, Canberra, Australian Capital Territory, Australia.
- Westmead Institute for Medical Research, Centre for Virus Research, Westmead, New South Wales, Australia.
- Department of Public and Ecosystem Health, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
- Centre for Planetary Health and Food Security, School of Environment and Science, Griffith University, Nathan, Queensland, Australia.
ORCID-Profile: Andrew Z Ma, Yao Yu Yeo, John-Sebastian Eden, Hector C Aguilar
Förderung
- NIAID NIH HHS
- NIBIB NIH HHS
- DARPA
- ARC DECRA
- HHS | NIH | National Institute of Allergy and Infectious Diseases
Zitieren
APA
Ma, A. Z., Yeo, Y. Y., Lee, J. F., Kim, C. M., Ezzatpour, S., Menchaca, C., Upadhye, V., Annand, E. J., Eden, J. S., Plowright, R. K., Peel, A. J., Buchholz, D. W., & Aguilar, H. C. (2025). Functional assessment of the glycoproteins of a novel Hendra virus variant reveals contrasting fusogenic capacities of the receptor-binding and fusion glycoproteins. mBio. https://doi.org/10.1128/mbio.03482-23
Vancouver
Ma AZ, Yeo YY, Lee JF, Kim CM, Ezzatpour S, Menchaca C, et al. Functional assessment of the glycoproteins of a novel Hendra virus variant reveals contrasting fusogenic capacities of the receptor-binding and fusion glycoproteins. mBio. 2025. doi:10.1128/mbio.03482-23
BibTeX
@article{Ma2025,
author = {Ma, Andrew Z and Yeo, Yao Yu and Lee, Jean F and Kim, Colin M and Ezzatpour, Shahrzad and Menchaca, Carolina and Upadhye, Viraj and Annand, Edward J and Eden, John-Sebastian and Plowright, Raina K and Peel, Alison J and Buchholz, David W and Aguilar, Hector C},
title = {Functional assessment of the glycoproteins of a novel Hendra virus variant reveals contrasting fusogenic capacities of the receptor-binding and fusion glycoproteins},
journal = {mBio},
year = {2025},
doi = {10.1128/mbio.03482-23}
}
EUVIMED